Gene20
ABCA2: ATP binding cassette subfamily A member 2
Cite this record
ConductScience Library. ABCA2: ATP binding cassette subfamily A member 2. Genes, record 20. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/20
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BZC7 | ATP-binding cassette sub-family A member 2 | 2,435 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260227408 A1 | 2026-08-06 | 511 | Q9BZC7 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 9231 | Q9BZC7 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 179 | Q9BZC7 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8979 | Q9BZC7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9231 | Q9BZC7 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 511 | Q9BZC7 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 8979 | Q9BZC7 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 179 | Q9BZC7 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 179 | Q9BZC7 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 179 | Q9BZC7 | Espacenet |
NIH grants486
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ABCA2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 7 | 2025 |
| ZIABC010030 | Biochemical Analysis of Multidrug Resistance-linked Transport Proteins | 4 | 2025 |
| P30CA138313 | Medical University of South Carolina - Cancer Center Support Grant | 3 | 2025 |
| ZIABC010830 | Mechanisms of non-classical multidrug resistance in cancer | 3 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 2 | 2025 |
| ZIABC005598 | Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells | 2 | 2025 |
| K12CA215110 | YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM | 1 | 2025 |
| P01AG052350 | Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease | 1 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 1 | 2025 |
Source NIH's project files
Papers833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improving Accuracy of Intracerebral Hemorrhage Volume Measurement Using Three-Dimensional Modeling and Physical Displacement. | Cerebrovasc Dis Extra | 2026 | 42809475 | PubTator, text mining | PubMed |
| Exploratory multi-omics analysis suggests context-dependent immune responses to vitamin D3 supplementation in PBMCs of multiple sclerosis patients. | Front Immunol | 2026 | 42601952 | PubTator, text mining | PubMed |
| Increased MYB alternative promoter usage induces daunorubicin resistance in human leukemia cells via ABCA2 upregulation. | Mol Biol Rep | 2026 | 42470473 | PubTator, text mining | PubMed |
| Increased Expression of miR-326 Mediates Chemosensitivity in Pediatric Acute Lymphoblastic Leukemia Through ABCA2 and YY1 Downregulation: An Observational and Experimental Study. | Health Sci Rep | 2026 | 42376363 | PubTator, text mining | PubMed |
| Expanding the ABCA2-associated neurodevelopmental phenotype. | HGG Adv | 2026 | 42357868 | PubTator, text mining | PubMed |
| A simplified geometric CMR method for reproducible quantification of left ventricular thrombus volume : Left Ventricular thrombus: a standardized measurement method. | Int J Cardiovasc Imaging | 2026 | 42295559 | PubTator, text mining | PubMed |
| Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma. | Cancer | 2026 | 41906217 | PubTator, text mining | PubMed |
| A switching-based deep learning framework for personalized and adaptive E-commerce recommendations. | Sci Rep | 2026 | 41735446 | PubTator, text mining | PubMed |
| Sustainable Conversion of Pulp Industry Sludge into Activated Biochar for High-Performance Methylene Blue Removal. | ACS Omega | 2026 | 41726677 | PubTator, text mining | PubMed |
| Rethinking emergency risk assessment: A single-center look at shock index and its variants in COVID-19. | PLoS One | 2026 | 41576058 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/20
GET https://conductscience.org/api/genes/v1/20/patents?page=2